Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3077 |
|
Actual shortage: | 235 (8%) | |
Anticipated shortage: | 16 (1%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2817 (92%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-PERINDOPRIL-INDAPAMIDE | 1.25MG 4MG | TABLET | Resolved | 2023-02-09 | 2023-09-22 | 184092 |
APO-OLANZAPINE | 20MG | TABLET | Resolved | 2023-02-09 | 2023-06-02 | 184097 |
APO-TADALAFIL | 5MG | TABLET | Resolved | 2023-02-09 | 2023-02-23 | 184109 |
APO-SITAGLIPTIN MALATE | 25MG | TABLET | Resolved | 2023-02-09 | 2023-04-06 | 184112 |
APO-LEVOFLOXACIN | 500MG | TABLET | Resolved | 2023-02-16 | 2023-05-19 | 185007 |
APO-LEVOFLOXACIN | 250MG | TABLET | Resolved | 2023-02-16 | 2023-05-06 | 185010 |
APO-MIRTAZAPINE | 15MG | TABLET | Resolved | 2023-02-16 | 2023-03-16 | 185013 |
APO-AMLODIPINE-ATORVASTATIN | 20MG 5MG | TABLET | Resolved | 2023-02-16 | 2023-03-02 | 185022 |
APO-AMLODIPINE-ATORVASTATIN | 80MG 10MG | TABLET | Resolved | 2023-02-16 | 2023-03-02 | 185025 |
APO-ALLOPURINOL | 200MG | TABLET | Resolved | 2023-02-16 | 2023-05-26 | 185028 |
APO-ALENDRONATE/VITAMIN D3 | 5600UNIT 70MG | TABLET | Resolved | 2023-02-16 | 2023-04-21 | 185033 |
APO-AMOXI CLAV | 125MG 875MG | TABLET | Resolved | 2023-02-16 | 2023-03-16 | 185039 |
APO-ACEBUTOLOL | 200MG | TABLET | Resolved | 2023-02-23 | 2023-03-16 | 185448 |
APO-DOXAZOSIN | 2MG | TABLET | Resolved | 2023-02-23 | 2023-03-23 | 185451 |
APO-NAPROXEN | 500MG | TABLET | Resolved | 2023-02-23 | 2023-05-06 | 185459 |
APO-VERAP TAB 80MG | 80MG | TABLET | Resolved | 2023-02-23 | 2023-03-02 | 185462 |
APO-PRAMIPEXOLE | 0.5MG | TABLET | Resolved | 2023-02-23 | 2023-04-14 | 185465 |
APO-LEVOFLOXACIN | 750MG | TABLET | Resolved | 2023-02-23 | 2023-05-06 | 185468 |
APO-ARIPIPRAZOLE | 10MG | TABLET | Resolved | 2023-02-23 | 2023-03-16 | 185477 |
APO-CEPHALEX | 500MG | TABLET | Resolved | 2023-02-23 | 2023-03-02 | 185480 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
APO-CETIRIZINE | Discontinued | 2018-05-31 | 2018-05-31 | 50998 | ||
APO-AMOXI CLAV 125MG/31.25MG PER 5ML | Discontinued | 2018-09-07 | 2018-09-15 | 60241 | ||
APO-CYCLOSPORINE ORAL SOLUTION | Discontinued | 2018-09-07 | 2018-09-15 | 60408 | ||
APO-FAMOTIDINE TAB 20MG USP | Discontinued | 2018-09-07 | 2018-09-15 | 60477 | ||
APO-FAMOTIDINE TAB 40MG USP | Discontinued | 2018-09-07 | 2018-09-15 | 60480 | ||
APO-FENTANYL MATRIX | Discontinued | 2018-09-07 | 2018-09-15 | 60494 | ||
APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
APO-LATANOPROST-TIMOP | Discontinued | 2018-09-07 | 2018-09-15 | 60572 | ||
APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60735 | ||
APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60738 | ||
APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60741 | ||
APO-RIZATRIPTAN RPD | Discontinued | 2018-09-08 | 2019-04-02 | 60756 | ||
APO-SILDENAFIL R | Discontinued | 2018-09-08 | 2018-09-15 | 60787 | ||
APO-AMOXI CLAV 125MG/31.25MG PER 5ML | Discontinued | 2018-12-21 | 2018-12-24 | 70347 | ||
APO-TIMOP | Discontinued | 2019-01-02 | 2019-01-02 | 70818 | ||
ACID CONTROL | Discontinued | 2019-01-03 | 2019-01-03 | 70906 | ||
APO-OFLOXACIN | Discontinued | 2019-01-03 | 2019-01-03 | 71017 | ||
APO-TIMOP GEL | Discontinued | 2019-01-03 | 2019-01-03 | 71020 | ||
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71029 |